StockData
EyePoint, Inc. logo

EyePoint, Inc. (EYPT) stock

EYPTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.30−0.01 (-3.80%)

Close on Nov 17, 2026Market cap $25.51MP/E –Yield –

EyePoint price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

EyePoint's price to sales ratio was 10.9× on Nov 11, 2026, against 24.4× a year earlier. Over the last 5 years it ranged from 2.4× to 156.7×, with a median of 10.4×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202610.9×−19.2
2025Dec 31, 202530.0×+21.3
2024Dec 31, 20248.7×−10.5
2023Dec 29, 202319.2×+16.4
2022Dec 30, 20222.8×−8.0
2021Dec 31, 202110.8×−18.4
2020Dec 31, 202029.2×−9.8
2019Dec 31, 201939.0×−8.6
2018Dec 31, 201847.6×+41.9
2017Dec 29, 20175.7×−35.2
2016Dec 30, 201640.8×−41.4
2015Dec 31, 201582.2×+78.0
2014Dec 31, 20144.3×−44.4
2013Dec 31, 201348.6×+37.0
2012Dec 31, 201211.6×+7.9
2011Dec 30, 20113.8×−0.4
2010Dec 31, 20104.2×–

More EyePoint figures

See a number that looks wrong?